Synvivia
“Cal Innovation Fund has been a great partner because they see what other investors can't. Instead of pattern matching or trend following, the CIF partners can be relied on for valuable first-principles analysis.”
— Gabriel Lopez , CEO and Founder
Synvivia is a biotechnology company founded by Gabriel Lopez, PhD from UC Berkeley, that is committed to revolutionizing gene therapy production through the chemical control of cell behavior. By leveraging this technology, Synvivia can optimize the packaging environment and alter any aspect of cell behavior for gene therapy production.